Aktie DLCL6 DR LALCHANDANI LABS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Dr Lalchandani Labs Limited

Aktien

DLCL6

INE871Z01013

DLCL6

Markt geschlossen - Bombay S.E.
Andere Börsenplätze
 12:00:51 10.05.2024 		% 5 Tage % 1. Jan.
21 INR +5,00 % Intraday Chart für Dr Lalchandani Labs Limited +6,06 % -1,08 %
02.05. Dr Lalchandani Labs Limited genehmigt die Ernennung von Namita Anand als Company Secretary und Compliance Officer CI
06.04. Dr Lalchandani Labs Limited gibt den Rücktritt von Karan Kumar als Company Secretary und Compliance Officer bekannt CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Dr Lalchandani Labs Limited Approves Appointment of Namita Anand as Company Secretary and Compliance Officer
Dr Lalchandani Labs Limited Announces Resignation of Karan Kumar as Company Secretary and Compliance Officer
Dr Lalchandani Labs Limited Announces the Resignation of Archana R Jha as Company Secretary and Compliance Officer
Dr Lalchandani Labs Limited Approves Resignation of Monika Joshi as Company Secretary and Compliance Officer
Dr Lalchandani Labs Limited Reports Earnings Results for the Half Year Ended September 30, 2023
Dr Lalchandani Labs Limited Announces Resignation of Archana Jha from the Office of Company Secretary
Dr Lalchandani Labs Limited Appoints Monika Joshi as Company Secretary and Compliance Officer, Effective August 27, 2023
Dr Lalchandani Labs Limited Announces Resignation of Archana R Jha as Company Secretary
Dr Lalchandani Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Dr Lalchandani Labs Limited Announces Management Changes
Dr Lalchandani Labs Limited Appoints Archana Jha as Company Secretary & Compliance Officer
Dr Lalchandani Labs Limited Reports Earnings Results for the Half Year Ended September 30, 2022
Dr Lalchandani Labs Limited Announces Resignation of CS Swati Poddar as Company Secretary and Compliance Officer
Dr Lalchandani Labs Limited Resumes in Full Capacity At the Lab in Punjabi Bagh
Dr Lalchandani Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2022
Dr Lalchandani Labs to Provide Diagnostic Services in Delhi, India, as Part of New Deal
Dr Lalchandani Labs Limited Appoints Swati Chandra as Additional Director
Dr Lalchandani Labs Limited Announces Resignation of Ms. Manica Gupta as Non-Executive Director
Dr Lalchandani Labs Limited Reports Earnings Results for the Half Year Ended September 30, 2021
Dr Lalchandani Labs' : Net Profit Soars in Fiscal Q4
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. DLCL6 Aktie
  4. Nachrichten Dr Lalchandani Labs Limited
  5. Andere Sprachen